XENON PHARMACEUTICALS INC. (XENE) /
The debt of XENON PHARMACEUTICALS INC. over the past 10 years
Chart XENON PHARMACEUTICALS INC.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, XENON PHARMACEUTICALS INC. had liquid cash of $548.89M and total debt of $0: net cash of $548.89M. It had more liquid cash than debt at all 10 year-ends shown. Total debt was highest at the end of fiscal 2019 ($15.54M) and lowest at the end of fiscal 2016 ($0).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $548.89M* | $0 | $548.89M |
| 2024ended Dec 31, 2024 | $626.9M* | $0 | $626.9M |
| 2023ended Dec 31, 2023 | $638.08M* | $0 | $638.08M |
| 2022ended Dec 31, 2022 | $592.09M* | $0 | $592.09M |
| 2021ended Dec 31, 2021 | $551.77M* | $0 | $551.77M |
| 2020ended Dec 31, 2020 | $177M* | $0 | $177M |
| 2019ended Dec 31, 2019 | $141.36M* | $15.54M | $125.82M |
| 2018ended Dec 31, 2018 | $119.31M* | $15.01M | $104.29M |
| 2017ended Dec 31, 2017 | $43.67M* | $6.8M | $36.86M |
| 2016ended Dec 31, 2016 | $64.15M* | $0 | $64.15M |
Fiscal years as XENON PHARMACEUTICALS INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on XENON PHARMACEUTICALS INC.
- The revenue of XENON PHARMACEUTICALS INC.
- The profitability of XENON PHARMACEUTICALS INC.
- The cash flow of XENON PHARMACEUTICALS INC.
- All of XENON PHARMACEUTICALS INC.'s financials, charted
Companies of a similar size
- BOOTBoot Barn Holdings, Inc.
- SMGScotts Miracle-Gro Co
- IRTINDEPENDENCE REALTY TRUST, INC.
- PRIMPrimoris Services Corporation
- BATRAATLANTA BRAVES HOLDINGS, INC.
Not investment advice. This page shows what XENON PHARMACEUTICALS INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.